Viva Biotech Unveils AI-Driven Drug Discovery Platform

Viva Biotech has launched its AI-Driven Drug Discovery platform, as announced in a press release. The platform, introduced during the 'Enchantment of Drug Discovery' event on May 13, 2025, features three core modules: V-Scepter, V-Orb, and V-Mantle, which aim to transform drug research and development processes.

The V-Scepter module includes tools for pocket identification, molecular docking, and ADMET prediction, while V-Orb focuses on virtual screening and molecular dynamics. V-Mantle leverages large language models for feature extraction and antibody engineering. These modules collectively enhance the efficiency and accuracy of drug discovery, significantly reducing the time and cost involved.

Viva Biotech's platform integrates AI algorithms with structural insights and real-time lab feedback, enabling faster progression of drug candidates to the lead optimization stage. This approach reduces development timelines from 2-4 years to under 1-2 years, cutting costs by 50-70%.